-
501
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budi...
Published 2024-10-01“…Secondary objectives were to assess safety and pharmacokinetics (PK), and exploratory objectives included evaluating preliminary efficacy.ResultsFifty-seven patients enrolled in the dose escalation: 23 in monotherapy cohorts and 34 in combination therapy cohorts. …”
Get full text
Article -
502
Nebulized aminoglycosides for ventilator-associated pneumonia: Methodological considerations and lessons from experimental studies
Published 2025-01-01“…Lung microdialysis is the only technique able to accurately assess lung pharmacokinetics in animals with inoculation pneumonia treated by nebulized aminoglycosides. …”
Get full text
Article -
503
Clinical and experimental rationale for using phenylephrine with hypromellose for the treatment of extra accommodation strain in patients with myopia
Published 2023-03-01“…</p> <p> <b>Conclusion</b>: the addition of hypromellose as an excipient to FDF of 2.5% phenylephrine solution helps to optimize pharmacodynamics and pharmacokinetics of the active ingredient by accelerating its inflow in the aqueous humor within the eye anterior chamber, increasing the topical bioavailability, and extending the exposure interval. …”
Get full text
Article -
504
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Published 2018-08-01“…These qualities formed the basis for development of the Russian pegilated interferon-alpha 2b (Pegaltevir®, LLC «FARMAPARK», Russia) and carrying out doublestaged randomized open clinical trial: study of safety, tolerability and pharmacokinetics of Pegaltevir® at single injection of increasing doses in various groups of healthy volunteers - the I stage; studying of efficacy and safety of Pegaltevir® in comparison to PegIntron® (Schering-Plough, USA) at CHC as a part of double antiviral therapy with ribavirin (Rebetol®, Schering-Plough, USA) - the II stage. …”
Get full text
Article -
505
Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kα inhibitors
Published 2025-02-01“…Molecular hybridization, with the advantage of simplified pharmacokinetics and drug-drug interactions, emerged as one of the important avenues for discovering potential drugs. …”
Get full text
Article -
506
Macrophage-mimicking nanotherapy for attenuation of acute pancreatitis
Published 2025-02-01“…However, systemically administered nanoparticle therapy is rapidly cleared from circulation by the mononuclear phagocyte system (MPS), leading to suboptimal drug concentrations in inflamed tissues and suboptimal pharmacokinetics. To address this challenge, we herein demonstrate a surface masking strategy that involves coating the surface of selenylated Poria cocos polysaccharide nanoparticles with a layer of macrophage plasma membrane to circumvent MPS sequestration, thereby enhancing the therapeutic efficacy of selenylated Poria cocos polysaccharide nanoparticles. …”
Get full text
Article -
507
Microarray Gene Expression Analysis of Murine Tumor Heterogeneity Defined by Dynamic Contrast-Enhanced MRI
Published 2002-07-01“…Using DCE-MRI in a murine subcutaneous tumor model, we were able to perform pharmacokinetic functional analysis of a tumor, coregistration of MRI images with histological cross-sections, immunohistochemistry, laser capture microdissection, and genetic profiling of tumor heterogeneity based on pharmacokinetic parameters. …”
Get full text
Article -
508
Comparative Bioavailability of Four Marketed Sparfloxacin Formulations in Healthy Human Volunteers
Published 2004-01-01“…The objective of the study was to obtain the pharmacokinetic data of four marketed tablet formulations of sparfloxacin and compare the relative bioavailability of the formulations with standard formulation. …”
Get full text
Article -
509
Physiologically Based Structure of Mean Residence Time
Published 2012-01-01“…Primarily this is because MRT structures cannot be identified by traditional pharmacokinetic methods used for the determination of MRT. …”
Get full text
Article -
510
Liquid Chromatography-Tandem Mass Spectrometric Assay for Determination of Stavudine in Human Plasma
Published 2014-01-01“…Stavudine was detected by a LC-MS/MS system. The pharmacokinetic parameters of stavudine in different formulations were calculated by noncompartment model statistics. …”
Get full text
Article -
511
Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS-CoV-2
Published 2024-01-01“…Molecular docking and in silico pharmacokinetic assays were used to assess 72 phytocompounds that are found in I. cylindrica as ligands and Mpro (6LU7) as the target. …”
Get full text
Article -
512
Development and validation of an LC-MS/MS method for the simultaneous estimation of tadalafil and macitentan in rat plasma: Greenness assessment and design of experiment approach
Published 2025-03-01“…This study presents the development and validation of a sensitive LC-MS/MS method for the simultaneous quantification of tadalafil and macitentan in rat plasma, enabling detailed pharmacokinetic profiling following single-dose administration. …”
Get full text
Article -
513
Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
Published 2013-01-01“…Patients were randomized to the active group, dosed using the nomogram, or to the control group, dosed using traditional pharmacokinetic calculations already in place at our institution. …”
Get full text
Article -
514
Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies
Published 2016-01-01“…Several guidelines and pharmacokinetic equations have been proposed as tools for CRRT drug dosing. …”
Get full text
Article -
515
Metabolic stability and its role in the discovery of new chemical entities
Published 2019-09-01“…Determination of metabolic profiles of new chemical entities is a key step in the process of drug discovery, since it influences pharmacokinetic characteristics of therapeutic compounds. …”
Get full text
Article -
516
Carboxylic Acid Bioisosteres in Medicinal Chemistry: Synthesis and Properties
Published 2022-01-01“…By chemically modifying a hit structure, an improved compound can be obtained in terms of activity, selectivity, and pharmacokinetic ADME (absorption, distribution, metabolism, and excretion) properties. …”
Get full text
Article -
517
Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
Published 2025-01-01“…These compounds exhibit favourable pharmacokinetic profiles and strong binding affinities for the five key targets associated with the disease. …”
Get full text
Article -
518
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Published 2018-01-01“…In this review, we describe these pharmacokinetic processes and explain how they may be influenced by drug-, formulation- and device-, and patient-related factors. …”
Get full text
Article -
519
Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction
Published 2016-01-01“…Clozapine provides a 50%–60% response rate in refractory schizophrenia but has a narrow therapeutic index and is susceptible to pharmacokinetic interactions, particularly with strong inhibitors or inducers of cytochrome P450 (CYP) 1A2. …”
Get full text
Article -
520
Combined therapeutic option for NDM-producing Serratia Marcescens – an in vitro study from clinical samples
Published 2025-01-01“…Concentrations used were those maximized by pharmacokinetic and pharmacodynamic assessments. Synergy evaluation involved a static macrodilution test followed by a time-kill curve assay. …”
Get full text
Article